Diabetic Macular Edema (DME) Withdrawn Phase 2 / 3 Trials for Fluocinolone acetonide (DB00591)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Withdrawn2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03784443Combined Ranibizumab and Iluvien for Diabetic Macular OedemaTreatment